Skip to main content
PLOS One logoLink to PLOS One
. 2023 Mar 1;18(3):e0280808. doi: 10.1371/journal.pone.0280808

Impact of digital meditation on work stress and health outcomes among adults with overweight: A randomized controlled trial

Rachel M Radin 1,*, Elissa S Epel 1, Ashley E Mason 1,2, Julie Vaccaro 1, Elena Fromer 1, Joanna Guan 1, Aric A Prather 1
Editor: Yann Benetreau3
PMCID: PMC9977041  PMID: 36857330

Abstract

Mindfulness meditation may improve well-being at work; however, effects on food cravings and metabolic health are not well known. We tested effects of digital meditation, alone or in combination with a healthy eating program, on perceived stress, cravings, and adiposity. We randomized 161 participants with overweight and moderate stress to digital meditation (‘MED,’ n = 38), digital meditation + healthy eating (‘MED+HE,’ n = 40), active control (‘HE,’ n = 41), or waitlist control (‘WL,’ n = 42) for 8 weeks. Participants (n = 145; M(SD) BMI: 30.8 (5.4) kg/m2) completed baseline and 8-week measures of stress (Perceived Stress Scale), cravings (Food Acceptance and Awareness Questionnaire) and adiposity (sagittal diameter and BMI). ANCOVAs revealed that those randomized to MED or MED+HE (vs. HE or WL) showed decreases in perceived stress (F = 15.19, p < .001, η2 = .10) and sagittal diameter (F = 4.59, p = .03, η2 = .04), with no differences in cravings or BMI. Those high in binge eating who received MED or MED+HE showed decreases in sagittal diameter (p = .03). Those with greater adherence to MED or MED+HE had greater reductions in stress, cravings, and adiposity (ps < .05). A brief digital mindfulness-based program is a low-cost method for reducing perceptions of stress and improving abdominal fat distribution patterns among adults with overweight and moderate stress. Future work should seek to clarify mechanisms by which such interventions contribute to improvements in health.

Trial registration: Clinical trial registration http://www.ClinicalTrials.gov: identifier NCT03945214.

Introduction

Obesity remains a public health crisis [1, 2] and it is highly comorbid with work-related stress [3]. Work stress contributes to an estimated 5–8% of annual healthcare costs in the United States [4]. Epidemiological studies consistently demonstrate associations between high work stress and worse self-reported mental and physical health, including depression, anxiety, cardiovascular disease, and type 2 diabetes [5].

Mindfulness meditation may improve well-being in workplace settings [6]. Mindfulness, in general, aims to cultivate a non-judging awareness of experiences in the present moment and promote adaptive self-regulation [7]. Mindfulness-based psychological interventions decrease perceptions of stress in non-clinical populations [8], and improve psychosocial outcomes in clinical populations with anxiety and depression [911]. Recent data indicate that mindfulness-based trainings delivered in the workplace decrease global perceptions of psychological stress in healthy adults [12]. However, traditional in-person practice cannot be easily scaled and disseminated, making them less cost-effective than other approaches. In the current study, we used a commercially available digitally-delivered meditation platform.

Overeating drive patterns, such as food cravings and binge eating, may explain the links between work stress and obesity. These eating patterns are strongly associated with obesity [1316] and worsened metabolic health [17] affecting up to 30% of those who seek weight-loss treatment [1820]. Overeating drive may uniquely predict the development of cardiovascular and endocrine disorders, including heart disease and type 2 diabetes, even after accounting for obesity status [17, 21]. These data support the importance of overeating drive as a behavioral target.

Mindfulness-based approaches may be a promising avenue for targeting reductions in overeating drive, including food cravings, and downstream metabolic outcomes. Mindfulness-based approaches are not diet-based, thus appealing to those with overeating drive patterns, who may have had many unsuccessful dieting attempts. There is little data assessing whether mindfulness approaches promote improvements in metabolic outcomes [22, 23]. It also remains unclear for whom mindfulness-based approaches are best suited. Our prior work on a weight loss intervention demonstrated that those with a tendency toward binge eating showed greater improvements in a range of weight-related factors following a mindfulness intervention compared to those without binge eating [24]. Thus, mindfulness-based approaches may be a better fit for adults with obesity and overeating drive, in comparison to standard behavioral weight loss interventions.

Mindfulness training delivered via a self-guided smartphone app may offer a convenient alternative to in-person treatment, though research on their efficacy is limited [25, 26]. Three small studies using smartphone apps to deliver mindfulness interventions to healthy adults found benefits comparable to traditional delivery methods on subjective well-being, depressive symptoms, and compassion [2729]. App-based interventions also offer the benefit of standardization of instruction across participants, as well as the ability for participants to control where and when they access the intervention, and objective measures of adherence, rather than self-report. Digital mindfulness interventions demonstrate significant reductions in perceived stress and increases in subjective mindfulness, compared to a wait list condition, among non-clinical populations [30]. A recent meta-analysis of digital occupational mental health interventions [31], which included mindfulness-based programs, found small, positive effects on psychological well-being and work effectiveness.

Treatment adherence to digitally-based mindfulness interventions is an understudied, yet probable moderator of treatment effects. In a recent 8-week pilot, Carolan and colleagues [32] found greater treatment engagement in digital programs incorporating a discussion group. It is also unknown whether digitally-based mindfulness interventions improve overeating drive or metabolic health. A recent meta-analysis [33] of in-person work-based mindfulness meditation programs found them generally effective in lowering cortisol production, heart rate, and sympathetic activity. Previous work using in-person mindfulness has shown that mindful eating training reduces abdominal fat without reducing overall body mass index [34, 35].

The Current Study: To test the effects of digital meditation on stress, cravings, and abdominal adiposity, we tested 4 conditions including an active control group with information about healthy eating, and a no treatment wait list control. The healthy eating program, which we considered to be an “active control” condition, utilized mindfulness-based and motivational approaches to improve eating behaviors. We aimed to test whether digital meditation could out-perform an active control condition that was matched for time and attention and other non-specific intervention effects [36]. We were interested in whether the adjunctive treatment offered from the healthy eating program would further improve outcomes compared to digital mindfulness alone.

We aimed to examine the effects of treatment randomization on global perceptions of psychological distress [37] and overeating drive [38]. Secondarily, we examined treatment effects on body mass index (BMI) and sagittal diameter. Finally, we examined the influence of treatment adherence (total minutes participants engaged in meditation on the app) on treatment outcomes. We hypothesized that mindfulness (in either form) would out-perform either control condition with respect to improvements in primary and secondary outcomes, and that treatment adherence would moderate these effects. We also anticipated that the combination of digital mindfulness + healthy eating (vs. digital mindfulness alone) would promote the greatest improvements. We also endeavored to examine the potential moderating role of binge eating presence. We hypothesized that those with binge eating would derive the greatest benefit from a mindfulness-based digital intervention, whereas those without binge eating would show no differences in outcomes across interventions.

Materials and methods

Study overview

We aimed to test the effects of a digital meditation intervention vs. an active or wait list control, on subjective measures of perceived stress, food cravings, and adiposity in a sample of employees at a large university with overweight and obesity who reported mild to moderate stress (NCT03945214). We randomized participants to 8-weeks of a digital meditation intervention (using the commercially available application, Headspace), a healthy eating intervention (active control), a digital meditation + healthy eating intervention, or a waitlist control condition. We asked all participants to complete questionnaires and anthropomorphic measurements at an in-person clinic visit at baseline and week 8. Adherence to the digital meditation intervention was tracked remotely by Headspace.

Participants

Eligible participants were ≥18 years old, employed at a large academic medical center, had a BMI equal to or greater than 25 kg/m2, reported mild to moderate levels of stress in the previous month (as determined by a Perceived Stress Scale score of 15 or higher), and had daily access to a smartphone or computer. Exclusion criteria included being an experienced meditator (defined as 3 times per week for 10 minutes or more). We obtained written informed consent from all study participants. We aimed to enroll up to 150 participants. Our prior study [39] detected effects in a sample of <250 participants. We therefore expected that our sample size of 150 would be well-powered to detect improvements in our self-report measures in response to our treatment intervention. The university’s Institutional review board (IRB) approved all aspects of this study. Participants did not receive monetary compensation; however they received a one-year subscription to Headspace (value of $150), and were entered into a raffle drawing to win a 2-night expenses paid vacation in the local Bay Area.

Study design

Participants completed baseline assessment procedures, including measures of body composition and self-report assessments. Study personnel then randomly assigned participants to one of four possible conditions, using factorial assignment, on Qualtrics: (1) Meditation only, (2) Healthy Eating only, (3) Meditation + Healthy Eating, or (4) Waitlist control. The sequence of assignments was generated ahead of time with a computer script by a statistician who was not involved in running the study. Study personnel were not able to access the file containing the sequence of assignments or to see the next condition in the sequence until the moment they randomized the participant. Both participants and study staff were unblinded to the assignment after allocation. We re-assessed participants on all measures collected at baseline (body composition, self-report assessments) again at 8 weeks from randomization.

Interventions

Meditation group (‘MED’)

We provided participants with access to digitally-based meditation program (Headspace app- Basics + ‘Letting go of stress’ packs) and asked them to engage with the app for at least 10 minutes a day for 8 weeks. We contacted participants who completed less than one meditation in the previous 10 to 17 days via phone, in order to re-engage them with the program. Participants were expected to meditate 5 days per week over the course of 8 weeks.

Healthy eating group (‘HE’)

Within week 1, we provided participants with an in-person 50-minute counseling session with a trained health counselor geared towards developing goals to improve eating behavior, along with three 10-minute booster phone calls at weeks 1, 4, and 8. The counseling session incorporated a motivational interviewing framework to assess areas of concern around eating behavior and to establish specific and achievable eating-related goals. We also asked participants to engage with a digitally-based mindful eating program once per week for 8 weeks, and sent text message reminders 3 times per week to increase accountability towards eating-related goals. The digitally-based mindful eating program was created specifically for this study by the research team, and was primarily a secured website that included information on mindful eating, and audio tools for mindful eating practice (~3–5 minute practices). This password-secured website contained up to six different brief audio exercises using mindful eating and urge-surfing strategies. The audio exercises were scripted and recorded by the study’s first author and adapted from a number of mindful eating resources including the mindfulness-based eating awareness training (MB-EAT) curriculum [45]. We instructed participants to access these audios during high vulnerability times for compulsive eating. For example, for those who identify cravings as a potent trigger for problematic consumption, participants could access a brief urge-surfing exercise to learn how to ‘ride out’ a craving. Participants had a total of approximately 1.5–2 hours of contact with a counselor, and were expected to engage with the online resources 1 day per week over the course of 8 weeks. The program is adapted from several sources, including motivational interviewing for binge eating, weight management, and sugar-sweetened beverage intake (from our recently completed trial), and mindfulness-based eating awareness training.

Meditation + healthy eating group (‘MED+HE’)

We provided participants with access to digitally-based meditation program (as described above under ‘MED’) in addition to the ‘HE’ program (as described above under ‘HE’). Participants were expected to meditate 5 days per week over the course of 8 weeks and they had a total of approximately 1.5–2 hours of contact with a counselor, and were expected to engage with the online resources 1 day per week over the course of 8 weeks.

Waitlist control condition (‘WL’)

We instructed participants to continue their normal activities and not add any meditation during the study period. We did not provide Headspace access codes to WL or HE participants until after they completed a 2-month follow-up questionnaire. Participants had no contact with a study counselor over the course of the 8 week intervention period.

Measures

Primary outcome measures

Perceived stress. The Perceived Stress Scale (PSS; [37] is a 10-item self-report questionnaire that measures a persons’ evaluation of the life stress they have experienced over the previous month, and has been extensively validated. The PSS has a total score scale range of 0 to 40, with higher values indicating more perceived stress. The PSS has demonstrated adequate reliability and validity among similar populations [37]. Among our study sample, scale reliability was high (α = .87)

Tolerance for food cravings

The Food Acceptance and Awareness Questionnaire (FAAQ) measures acceptance of urges and cravings to eat or the extent to which individuals might try to control or change these thoughts [38]. The FAAQ is made up of 10 items, each rated on a 6-point Likert scale (1 = very seldom true to 6 = always true). It has a total score scale range of 10 to 60, with higher scores indicating greater acceptance of motivations to eat and greater tolerance for food cravings. The FAAQ has demonstrated sound psychometric properties [38]. Among our study sample, scale reliability was high (α = .80).

Secondary outcome measures

BMI. We calculated body mass index (BMI) as weight in kilograms divided by the square of height in meters (kg/m2).Weight was measured twice using a digital scale, and height was measured using a stadiometer.

Sagittal diameter. We measured body fat distribution using an abdominal caliper placed just above the umbilicus, measuring the distance from the small of the back to the upper abdomen. Measurements were taken, using the two closest measurements that were within 0.5 cm, and recorded to the nearest 0.1 cm.

Binge presence. We used the Questionnaire on Eating and Weight Patterns –5 (QEWP-5) to determine the presence of binge eating. The QEWP-5 [40] is a 24-item questionnaire that assesses frequency of reported binge eating and loss of control eating episodes, which has been shown to have reasonable agreement with interview-based measures such as the Eating Disorder Examination [40]. Binge presence was defined by the endorsement of the following: 1- During the last 3 months, did you ever eat, in a short period of time- for example, a two hour period- what most people would think was an unusually large amount of food?; 2- During the times when you ate an unusually large amount of food, did you often feel you could not stop eating or control what or how much you were eating?

Treatment adherence

Adherence to either meditation program (MED or MED+HE) was calculated by summing the total number of minutes spent meditating via Headspace over 8 weeks. The research team had access to individual user data via Headspace, in order to make these calculations. We also assessed meditation frequency with the following questions: “How often did you practice sitting meditation (for 10 min or more) in the past 8 weeks?” Participants selected of the following options: never, less than once a week, 1–3 times per month, 1–2 times per week, 3–4 times per week, or every day. We used this information to ensure that those in the control conditions (active and wait list control) abstained from meditation practice throughout the intervention period.

Statistical analysis

Data preparation

We used SPSS (Version 27.0. Armonk, NY: IBM Corp.) for all variable preparation and statistical analysis. We computed summary statistics to evaluate the distributions of each study variable (i.e., PSS, FAAQ, BMI, sagittal diameter, binge presence, treatment adherence) and assess potential outliers. We did not find any outliers with regard to primary or secondary outcome variables (defined as > ± 3 standard deviations of the mean).

Treatment effect on outcome variables

In a series of Analysis of Covariance (ANCOVA) models, we compared treatment groups (IV: MED vs. MED+HE vs. HE vs. WL) on each 8-week outcome variable (DV: Treatment adherence, PSS, FAAQ, BMI, Sagittal Diameter), adjusting for baseline value of each corresponding measure (covariate). If the main ANCOVA model was significant, we used post-hoc (least square differences) tests to explore group differences. In sub-analyses, we ran an identical series of ANCOVA models, where we collapsed treatment groups (IV) into ‘meditation’ (MED or MED+HE) vs. ‘no meditation’ (HE or WL).

Moderation analyses

We ran a series of ANCOVA models adding an interaction term between treatment group and total meditation minutes (treatment adherence) and examined the simple slopes of the interaction term. We also ran a series of linear regressions to explore whether baseline binge presence (treated as a dichotomous variable of binge vs. no binge presence) moderated the effect of treatment group on primary and secondary outcome variables. We created an interaction term (between binge presence at baseline X intervention) as our independent variable. In all analyses, we considered p ≤.05 to be statistically significant (using two-tailed tests).

Results

Participant recruitment and retention

We enrolled 161 participants, who we randomized to: MED (n = 38), MED+HE (n = 40), HE (n = 41), or WL (n = 42). At 8 weeks, 145 participants completed follow-up surveys and 128 participants completed an in-person follow-up visit (see Fig 1 for CONSORT diagram).

Fig 1. CONSORT flow diagram.

Fig 1

Participant characteristics

Participants had a mean BMI of 30.78 kg/m2 (40% with obesity vs. 60% with overweight). The majority (40%) identified as White, and reported a four-year college or graduate degree (85%). We classified the majority of participants as administrative staff (30%), researchers (19%) mid-level managers (16%) or medical staff (15%). By study design, participants endorsed a mean PSS score indicative of moderate stress (37) and the majority (>95%) reported meditating less than once a week. Approximately 39% endorsed binge eating presence (objectively large amount of food + loss of control; Tables 1 and 2 for demographic and health characteristics of the sample, respectively).

Table 1. Baseline demographics.

Variable Total Sample Meditation Meditation + Healthy Eating Healthy Eating Waiting list Control
  n n   n   n   n  
Demographics
Age (years) (M±SD) 161 37.92 ± 11.18 38 38.63 ± 11.01 40 35.40 ± 8.03 41 39.29 ± 12.43 42 38.33 ± 12.55
Sex (% female) 161 72 38 71.05% 40 67.50% 41 82.93% 42 66.67%
Race/Ethnicity (%): 161 38 40 41 42
White 39.8 16 42.11% 14 35.00% 14 34.15% 20 47.62%
Black or African American 9.3 3 7.89% 5 12.50% 4 9.76% 3 7.14%
Hispanic or Latino 12.4 7 18.42% 6 15.00% 5 12.20% 2 4.76%
Asian/Pacific Islander 21.1 6 15.79% 8 20.00% 7 17.07% 13 30.95%
Multiple races 13.7 4 10.53% 7 17.50% 7 17.07% 4 9.52%
Other 3.7 2 5.26% 0 0.00% 4 9.76% 0 0.00%
Education (y) (%): 161 38 40 41 42
Less than 4 year degree 11.8 6 15.78% 5 12.50% 4 9.76% 4 9.52%
4 year degree 39.1 12 31.58% 16 40.00% 19 46.34% 16 38.10%
Professional degree 32.3 11 28.95% 12 30.00% 14 34.15% 15 35.71%
Doctorate 13.7 7 18.42% 6 15.00% 4 9.76% 5 11.90%
No response 3.1 2 5.26% 1 2.50% 0 0.00% 2 4.76%
Annual household income (%): 161 38 40 41 42
Less than $35,000 4.4 3 7.89% 1 2.50% 2 4.88% 1 2.38%
$35,000 to less than $50,000 5.0 1 2.63% 1 2.50% 3 7.32% 3 7.14%
$50,000 to less than $75,000 20.5 9 23.68% 10 25.00% 4 9.76% 10 23.81%
$75,000 to less than $100,000 18.0 5 13.16% 8 20.00% 11 26.83% 5 11.90%
$100,000 to less than $150,000 21.1 8 21.05% 10 25.00% 8 19.51% 8 19.05%
$150,000 to less than $200,000 14.9 6 15.79% 3 7.50% 7 17.07% 8 19.05%
$200,000 or more 11.8 4 10.53% 6 15.00% 5 12.20% 4 9.52%
Prefer not to answer/no response 4.3 2 5.26% 1 2.50% 1 2.44% 3 7.14%

Table 2. Baseline health characteristics.

Variable Total Sample Meditation Meditation + Healthy Eating Healthy Eating Waiting list Control
  n n   n   n   n  
Physiological Characteristics (M±SD):
BMI (kg/m2) 161 30.78 ± 5.43 38 30.10 ± 4.49 40 31.17 ± 6.39 41 30.98 ± 5.07 42 30.80 ± 5.69
Sagittal Diameter (cm) 161 25.73 ± 5.14 38 24.85 ± 5.00 40 25.88 ± 5.80 41 26.01 ± 5.08 42 26.11 ± 4.75
Stress, Psychological Measures (M±SD):
Perceived Stress Scale 160 21.88 ± 4.84 38 22.00 ± 5.59 40 22.38 ± 4.68 41 21.68 ± 4.36 41 21.46 ± 4.86
Meditation frequency (%) 161 38 40 41 42
Never 78.9 68.4 85 80.5 81
Less than once a month 9.3 18.4 5 7.4 7.1
1–3 times a month 7.5 7.9 5 7.3 9.5
1–2 times a week 4.3 5.3 5 4.9 2.4
Eating Measures (M±SD):
Food Acceptance and Action Questionnaire (FAAQ) 155 29.20 ± 6.49 37 29.41 ± 6.56 38 29.53 ± 6.69 41 28.78 ± 6.37 39 29.13 ± 6.56
Binge eating presence (%) (QEWP)a 160 38.5 38 34.21% 40 37.50% 41 46.34% 42 35.71%
# Binge episodes per week (QEWP) 160 0.91 ± 1.40 38 0.84 ± 1.35 39 0.97 ± 1.55 41 1.12 ± 1.47 42 0.71 ± 1.24

a QEWP = Questionnaire on Eating and Weight Patterns [38]. Binge presence was defined by the endorsement of the following: 1- During the last 3 months, did you ever eat, in a short period of time- for example, a two hour period- what most people would think was an unusually large amount of food?; 2- During the times when you ate an unusually large amount of food, did you often feel you could not stop eating or control what or how much you were eating?

Treatment adherence

Participants randomized to MED or MED+HE (n = 78) engaged with the Headspace app an average of 4.15 ± 4.22 minutes per day with no differences between meditation groups (t = 1.50, p = .14). Approximately 10% (n = 8) were adherent to instructions to meditate ≥10 minutes per day over the course of the 8 week program. Participants randomized MED or MED+HE (vs. HE or WL) reported a greater frequency of meditation at 8 weeks, after accounting for baseline frequency (F = 78.51, p < .001). The majority of those in MED (83%) or MED+HE (72%) reported meditating up to two times per week at 8 weeks (compared to 9% of those in HE and 3% of those in WL), suggesting that both mindfulness groups were adherent to treatment (i.e., engaging in mindfulness).

Primary outcomes

Perceived stress

Among all 4 groups, there was a treatment effect (F(3,139) = 5.91, p = .001, η2 = .11), such that those in MED (mean change: -5.97, SE = 0.94, 95% CI: -7.84, -4.11) or MED+HE (mean change: -4.97, SE = 0.99, 95% CI: -6.92, -3.02) showed the greatest decreases in PSS score (with no differences between MED vs. MED+HE, p = .30), compared to those in HE (mean change: -2.00, SE = 0.93, 95% CI: -3.84, -0.16) or WL (mean change: -1.66, SE = 0.92, 95% CI: -3.48, 0.16); with no differences between HE vs. WL, p = .80; Fig 2). In sub-analyses, those randomized to either ‘meditation’ (i.e., MED or MED+HE) group showed greater decreases in PSS score (26% reduction) vs. those in either ‘no meditation (i.e., HE or WL)’ group (8% reduction; F(1,142 = 15.19, p < .001, η2 = .10). Findings were identical when using non-parametric tests (Kruskal-Wallis), given the ordinal nature of the PSS scoring. Frequency of meditation moderated the effect of treatment on changes in PSS (interaction term, F = 4.74, p = .03), such that greater treatment adherence in meditation was associated with greater decreases in PSS score at 8 weeks (r = -.27, p = .03).

Fig 2. Effect of treatment randomization on perceived stress (PSS) at 8 weeks, accounting for baseline values.

Fig 2

Tolerance for food cravings

Among all 4 groups, we found no treatment effect (F(3,132) = 0.58, p = .63, η2 = .01). Comparing the estimated marginal means showed a pattern (while not significant) that those in HE showed the greatest increases in FAAQ (mean change: +1.80, SE = 1.37, 95% CI: -0.91, 4.51), followed by those in WL (mean change: +0.81, SE = 1.33, 95% CI: -1.83, 3.45), MED (mean change: +0.26, SE = 1.37, 95% CI: -2.46, 2.97) and MED+HE (mean change: -0.83, SE = 1.51, 95% CI: -3.81, 2.15; Fig 3). In sub-analyses, those randomized to ‘meditation’ vs. ‘no meditation’ did not differ; Both groups showed similar changes (meditation: 0.10% reduction; vs no meditation: 4.3% increase; F(1,134 = 1.21, p = .27, η2 = .01). Findings were identical when using non-parametric tests (Kruskal-Wallis), given the ordinal nature of the FAAQ scoring. Frequency of meditation did not moderate the effect of treatment on changes in FAAQ (p>.10). However, we observed a main effect of meditation frequency on FAAQ at 8-weeks (F = 5.31, p = .02), irrespective of treatment randomization. Treatment adherence was associated with higher FAAQ scores at 8-weeks (r = .27, p = .03), although it was not associated with changes in FAAQ score at 8 weeks (r = .20, p = .12).

Fig 3. Effect of treatment randomization on Tolerance for Food Cravings (FAAQ) at 8 weeks, accounting for baseline values.

Fig 3

Secondary outcomes

Sagittal diameter

Among all 4 treatment groups, we found no treatment effect (F(3,124) = 1.69, p = .18 = 7; η2 = .04). Comparing the estimated marginal means showed a pattern (while not significant) that those in MED+HE (mean change: -0.25, SE = 0.24, 95% CI: -0.72, 0.22) and MED (mean change: -0.12; SE = 0.23, 95% CI: -0.57, 0.33) showed decreases in sagittal diameter, whereas those in HE (mean change:+0.41, SE = 0.23, 95% CI: -0.05, 0.86) and WL (mean change: +0.21, SE = 0.23, 95% CI: -0.24, 0.66) showed slight increases. In sub-analyses, those randomized to either ‘meditation’ group showed greater decreases in sagittal diameter (-0.19 cm; 1% reduction) vs. those in either ‘no meditation’ group (+0.31 cm; 1% increase; F(1,126) = 4.59, p = .03; η2 = .04, Fig 4). Frequency of meditation did not moderate the effect of treatment randomization on changes in sagittal diameter. However, we observed a main effect of meditation frequency on sagittal diameter at 8-weeks (F = 15.21, p < .001), irrespective of treatment randomization. Treatment adherence was associated with greater decreases in sagittal diameter at 8 weeks (r = -.45, p < .001).

Fig 4. Effect of treatment randomization on sagittal diameter at 8 weeks, accounting for baseline values.

Fig 4

BMI

Among all 4 treatment groups, we found no treatment effect (F(3,124) = 1.61, p = .19, η2 = .04) Comparing the estimated marginal means showed a pattern (while not significant) that those in MED+HE (mean change: -.66, SE = 0.29, 95% CI: -1.25, -0.08) showed slight decreases in BMI, whereas those in HE (mean change: +0.04, SE = 0.28, 95% CI: -0.52, 0.60), WL (mean change: +0.06, SE = 0.28, 95% CI: -0.50, 0.61) and MED (mean change: +0.11, SE = 0.28, 95% CI: -0.44, 0.67) showed slight increases. In sub-analyses, those randomized to ‘meditation’ vs. ‘no meditation’ did not differ; Both groups showed similar changes (meditation: -0.26 kg/m2; 1% reduction; vs no meditation: +0.05; 1% reduction; F(1,126) = 1.13, p = .29; η2 = .01). Frequency of meditation did not moderate the effect of treatment randomization on changes in BMI. Treatment adherence was not associated with changes in BMI at 8-weeks (r = -.03, p = .83).

Moderation by baseline binge eating status

We did not observe a main effect of treatment randomization on binge presence at 8 weeks, (chi2 = 0.78, p = .46). We did not find evidence for a moderating effect of baseline binge presence on our primary outcome variables (PSS, FAAQ, ps for interaction terms>.50). However, baseline binge presence moderated the effect of treatment randomization on changes in sagittal diameter at 8 weeks (F(1,123) = 4.95, p = .03, η2 = .04). Examining the simple slopes of this interaction term showed that the association between treatment randomization and sagittal diameter was stronger among those with binge presence but not among those without binge presence. Participants with baseline binge presence showed greater decreases in sagittal diameter if randomized to the meditation (vs. no meditation) group, whereas participants without binge presence did not differ in sagittal diameter changes based on treatment randomization (Fig 5). We observed a similar interaction effect on changes in BMI, although this effect approached statistical significance (F(1,123) = 3.09, p = .08, η2 = .03), such that those who reported binge presence tended to derive the greatest benefit when randomized to meditation vs. no meditation.

Fig 5. Associations between treatment randomization and changes in sagittal diameter at 8 weeks among those with (n = 53) vs. without (n = 75) baseline binge presence.

Fig 5

Discussion

Participants with overweight and moderate stress, who received either one of the digitally-based mindfulness programs showed expected reductions in perceived stress, thus confirming prior findings [30, 31]. We also found a small, but significant treatment effect on reductions in sagittal diameter. Contrary to our hypothesis, there was no treatment effect on food cravings or BMI. In an exploratory analysis, we found that meditators who also reported binge eating significantly reduced sagittal diameter.

We found preliminary evidence for a moderating effect of treatment adherence on reductions in perceived stress. Furthermore, meditation frequency was positively associated with greater tolerance for food cravings and decreases in sagittal diameter. It is plausible that treatment adherence, measured by meditation frequency using the Headspace app, accounts for treatment effects in a dose-like fashion, and suggests a mechanistic pathway, promoting reductions in stress, food cravings, and abdominal fat.

Few digitally-based mindfulness interventions have examined treatment effects on weight and metabolic outcomes [33]. We found a small but significant treatment effect on reductions in sagittal diameter, despite no reductions in BMI. In-person mindfulness interventions have improved some physiological outcomes, including blood pressure, glucose, and abdominal fat [34, 35, 41, 42] despite no changes in BMI. To our knowledge, this is this first digitally-based mindfulness intervention to observe such an effect on abdominal fat distribution. Given the main effect of treatment adherence on reductions in sagittal diameter, it is plausible that this effect is mediated by stress-related pathways, including reductions in cortisol. We found that reduction in perceived stress were associated with reductions in sagittal diameter and increases in awareness of food cravings (ps≤.05). It is plausible that participants who received digital mindfulness may make healthier eating choices (e.g., increased mindfulness around satiety/hunger) which may contribute to downstream metabolic improvements. However, we were not adequately powered to test such a mechanistic pathway. This finding may also point to the importance of measuring abdominal fat distribution, in addition to BMI, in mindfulness-based digital trials.

Contrary to our hypothesis, we did not find a treatment effect on food cravings. However, the mindfulness groups reduced in binge eating (although this finding approached statistical significance). Thus, we were unable to replicate known effects of in-person mindfulness-based and mindful eating-based interventions on reductions in dysregulated eating [4346]. Further, the addition of a healthy eating program did not add a beneficial effect to our primary or secondary outcomes. Both digital mindfulness groups (alone or with healthy eating) performed equally well with regard to reductions in perceived stress and sagittal diameter.

It should be noted that the healthy eating (active control) program was newly developed, and in need of further refining following feasibility and acceptability testing. Participants randomized to healthy eating showed good adherence (only 4% declined participation following the initial counseling session). The majority (73%) of participants rated the program as ‘good’ to ‘excellent’, and 91% of completers would recommend the program. Thus, while the healthy eating program, as packaged, did not reduce our measures of food craving, the feasibility data provided the necessary preliminary evidence for future refinement and testing. Qualitative data point to the potential added value of face-to-face counseling to establish health-related eating goals. It is plausible that participants first need to learn general mindfulness skills before showing eating-related improvements.

Finally, while exploratory in nature, we replicated our prior findings with regard to treatment matching [24], such that participants with baseline binge presence showed the greatest decreases in sagittal diameter in the meditation (vs. no-meditation) group. These findings suggest that mindfulness may be a better fit for adults with overweight and overeating drive, in comparison to treatment as usual. We did not actively recruit participants high in binge eating, although nearly 40% endorsed engaging in some level of binge eating. Future RCTs should specifically seek to recruit adults with both overweight and binge eating, to fully examine whether mindfulness-based digital approaches contribute to greater improvements in psychological and metabolic health among this high-risk group.

This study had several strengths. We were able to deliver a primarily self-guided, scalable treatment for meditation to adults who experienced both perceived stress and overweight. We observed generally good adherence to our digital intervention, with only 11% being lost to follow-up. We had the added benefit of being able to compare our treatment (mindfulness) to what we considered to be an active control (healthy eating) matched for time and attention. However, our study was likely limited by a sample size that may have been too small to detect modest interaction effects. We were unable to truly ascertain whether participants in either control condition were accessing mindfulness programs or apps during the 8 week intervention period. Further, our measures of dysregulated eating may not fully reflect non-homeostatic eating behavior (vs. a semi-structured interview measure of eating pathology), and the scoring metrics for the FAAQ (a 6-point Likert scale ranging from 1 to 6) without the option for including negative (e.g., -1, -2) response may not yield particularly meaningful arithmetic means. Finally, our sample of participants were highly educated and primarily White. Thus, our findings may not fully generalize to the US population of adults with overweight.

Conclusions

A brief digital mindfulness-based intervention is a low-cost method to reduce perceived measures of stress and may have the potential to reduce abdominal fat distribution among adults with overweight and moderate stress. These findings add to the existing literature documenting salutary effects of mindfulness on reports of well-being and extends it to digital-based mindfulness interventions. Future work should seek to clarify mechanisms by which digitally-based mindfulness interventions may contribute to improvements in psychological and physiological health.

Supporting information

S1 Checklist. CONSORT 2010 checklist of information to include when reporting a randomised trial*.

(DOC)

S1 File

(DOCX)

S2 File

(PDF)

Acknowledgments

We gratefully acknowledge our participants for donating their time to this study.

Data Availability

The data described in the manuscript, code book, and analytic code/syntax are made publicly and freely available through Open Science Framework Repository. The DOI Identifier is: DOI 10.17605/OSF.IO/QPG6F.

Funding Statement

This work was supported by the UCSF Healthy Campus Network; Headspace, Inc.; and the National Center for Complementary and Integrative Health (NCCIH) K23AT011048-01 (to RMR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.The university’s Institutional review board (IRB) approved all aspects of this study. All authors report no non-financial interests that could be relevant to the submitted manuscript. Dr. Elissa Epel is a scientific advisor to Meru Health, Inc., a digital platform for mental health.

References

  • 1.Flegal KM, Carroll MD, Kit BK, Ogden CL. Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999–2010. Jama. 2012;307(5):491–7. doi: 10.1001/jama.2012.39 [DOI] [PubMed] [Google Scholar]
  • 2.Ogden CL, Carroll MD, Fryar CD, Flegal KM. Prevalence of obesity among adults and youth: United States, 2011–2014. 2015. [PubMed] [Google Scholar]
  • 3.Heraclides AM, Chandola T, Witte DR, Brunner EJ. Work Stress, Obesity and the Risk of Type 2 Diabetes: Gender-Specific Bidirectional Effect in the Whitehall II Study. Obesity. 2012;20(2):428–33. doi: 10.1038/oby.2011.95 [DOI] [PubMed] [Google Scholar]
  • 4.Goh J, Pfeffer J, Zenios SA. The relationship between workplace stressors and mortality and health costs in the United States. Management Science. 2016;62(2):608–28. [Google Scholar]
  • 5.Ganster DC, Rosen CC. Work stress and employee health: A multidisciplinary review. Journal of management. 2013;39(5):1085–122. [Google Scholar]
  • 6.Jamieson SD, Tuckey MR. Mindfulness interventions in the workplace: A critique of the current state of the literature. Journal of Occupational Health Psychology. 2017;22(2):180. doi: 10.1037/ocp0000048 [DOI] [PubMed] [Google Scholar]
  • 7.Brown KW, Ryan RM, Creswell JD. Mindfulness: Theoretical Foundations and Evidence for its Salutary Effects. Psychological Inquiry. 2007;18(4):211–37. [Google Scholar]
  • 8.Chiesa A, Serretti A. Mindfulness-based stress reduction for stress management in healthy people: a review and meta-analysis. The journal of alternative and complementary medicine. 2009;15(5):593–600. doi: 10.1089/acm.2008.0495 [DOI] [PubMed] [Google Scholar]
  • 9.Bohlmeijer E, Prenger R, Taal E, Cuijpers P. The effects of mindfulness-based stress reduction therapy on mental health of adults with a chronic medical disease: a meta-analysis. Journal of psychosomatic research. 2010;68(6):539–44. doi: 10.1016/j.jpsychores.2009.10.005 [DOI] [PubMed] [Google Scholar]
  • 10.Kuyken W, Warren FC, Taylor RS, Whalley B, Crane C, Bondolfi G, et al. Efficacy of mindfulness-based cognitive therapy in prevention of depressive relapse: an individual patient data meta-analysis from randomized trials. JAMA psychiatry. 2016;73(6):565–74. doi: 10.1001/jamapsychiatry.2016.0076 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Hofmann SG, Heering S, Sawyer AT, Asnaani A. How to handle anxiety: The effects of reappraisal, acceptance, and suppression strategies on anxious arousal. Behaviour research and therapy. 2009;47(5):389–94. doi: 10.1016/j.brat.2009.02.010 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Virgili M. Mindfulness-based interventions reduce psychological distress in working adults: a meta-analysis of intervention studies. Mindfulness. 2015;6(2):326–37. [Google Scholar]
  • 13.Bruce B, Agras WS. Binge eating in females: A population‐based investigation. International Journal of Eating Disorders. 1992;12(4):365–73. [Google Scholar]
  • 14.Striegel-Moore RH, Franko DL. Should binge eating disorder be included in the DSM-V? A critical review of the state of the evidence. Annu Rev Clin Psychol. 2008;4:305–24. doi: 10.1146/annurev.clinpsy.4.022007.141149 [DOI] [PubMed] [Google Scholar]
  • 15.Wonderlich SA, Gordon KH, Mitchell JE, Crosby RD, Engel SG. The validity and clinical utility of binge eating disorder. The International journal of eating disorders. 2009;42(8):687–705. doi: 10.1002/eat.20719 [DOI] [PubMed] [Google Scholar]
  • 16.Hudson J, Hiripi E, Pope HG, Kessler RC. The prevalence and correlates of eating disorders in the National Comorbidity Survey Replication. Biological psychiatry. 2007;61(3):348–58. doi: 10.1016/j.biopsych.2006.03.040 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Hudson J, Lalonde JK, Coit CE, Tsuang MT, McElroy SL, Crow SJ, et al. Longitudinal study of the diagnosis of components of the metabolic syndrome in individuals with binge eating disorder. Am J Clin Nutr. 2010. doi: 10.3945/ajcn.2010.29203 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Kessler RC, Berglund PA, Chiu WT, Deitz AC, Hudson JI, Shahly V, et al. The prevalence and correlates of binge eating disorder in the World Health Organization World Mental Health Surveys. Biological Psychiatry. 2013;73(9):904–14. doi: 10.1016/j.biopsych.2012.11.020 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.de França GVA, Gigante DP, Olinto MTA. Binge eating in adults: prevalence and association with obesity, poor self-rated health status and body dissatisfaction. Public health nutrition. 2014;17(04):932–8. doi: 10.1017/S1368980013000591 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Ivezaj V, White MA, Grilo CM. Examining binge‐eating disorder and food addiction in adults with overweight and obesity. Obesity. 2016;24(10):2064–9. doi: 10.1002/oby.21607 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Tanofsky-Kraff M, Shomaker LB, Stern EA, Miller R, Sebring N, Dellavalle D, et al. Children’s binge eating and development of metabolic syndrome. Int J Obes (Lond). 2012;36(7):956–62. doi: 10.1038/ijo.2011.259 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Goyal M, Singh S, Sibinga EM, Gould NF, Rowland-Seymour A, Sharma R, et al. Meditation programs for psychological stress and well-being: a systematic review and meta-analysis. JAMA Internal Medicine. 2014;174(3):357–68. doi: 10.1001/jamainternmed.2013.13018 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Godfrey KM, Gallo LC, Afari N. Mindfulness-based interventions for binge eating: a systematic review and meta-analysis. J Behav Med. 2015;38(2):348–62. doi: 10.1007/s10865-014-9610-5 [DOI] [PubMed] [Google Scholar]
  • 24.Radin RM, Epel ES, Daubenmier J, Moran P, Schleicher S, Kristeller J, et al. Do stress eating or compulsive eating influence metabolic health in a mindfulness-based weight loss intervention? Health Psychol. 2020;39(2):147–58. doi: 10.1037/hea0000807 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Donker T, Petrie K, Proudfoot J, Clarke J, Birch MR, Christensen H. Smartphones for smarter delivery of mental health programs: a systematic review. J Med Internet Res. 2013;15(11):e247. doi: 10.2196/jmir.2791 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Fairburn CG, Patel V. The impact of digital technology on psychological treatments and their dissemination. Behav Res Ther. 2017;88:19–25. doi: 10.1016/j.brat.2016.08.012 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Howells A, Ivtzan I, Eiroa-Orosa FJ. Putting the ‘app’in happiness: a randomised controlled trial of a smartphone-based mindfulness intervention to enhance wellbeing. Journal of happiness studies. 2016;17(1):163–85. [Google Scholar]
  • 28.Lim D, Condon P, DeSteno D. Mindfulness and compassion: an examination of mechanism and scalability. PLoS One. 2015;10(2):e0118221. doi: 10.1371/journal.pone.0118221 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Ly KH, Truschel A, Jarl L, Magnusson S, Windahl T, Johansson R, et al. Behavioural activation versus mindfulness-based guided self-help treatment administered through a smartphone application: a randomised controlled trial. BMJ Open. 2014;4(1):e003440. doi: 10.1136/bmjopen-2013-003440 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Jayewardene WP, Lohrmann DK, Erbe RG, Torabi MR. Effects of preventive online mindfulness interventions on stress and mindfulness: A meta-analysis of randomized controlled trials. Prev Med Rep. 2017;5:150–9. doi: 10.1016/j.pmedr.2016.11.013 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Carolan S, Harris PR, Cavanagh K. Improving Employee Well-Being and Effectiveness: Systematic Review and Meta-Analysis of Web-Based Psychological Interventions Delivered in the Workplace. J Med Internet Res. 2017;19(7):e271. doi: 10.2196/jmir.7583 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Carolan S, Harris PR, Greenwood K, Cavanagh K. Increasing engagement with an occupational digital stress management program through the use of an online facilitated discussion group: Results of a pilot randomised controlled trial. Internet Interv. 2017;10:1–11. doi: 10.1016/j.invent.2017.08.001 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Heckenberg RA, Eddy P, Kent S, Wright BJ. Do workplace-based mindfulness meditation programs improve physiological indices of stress? A systematic review and meta-analysis. J Psychosom Res. 2018;114:62–71. doi: 10.1016/j.jpsychores.2018.09.010 [DOI] [PubMed] [Google Scholar]
  • 34.Daubenmier J, Moran PJ, Kristeller J, Acree M, Bacchetti P, Kemeny ME, et al. Effects of a mindfulness-based weight loss intervention in adults with obesity: A randomized clinical trial. Obesity (Silver Spring, Md). 2016;24(4):794–804. doi: 10.1002/oby.21396 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Daubenmier J, Kristeller J, Hecht FM, Maninger N, Kuwata M, Jhaveri K, et al. Mindfulness Intervention for Stress Eating to Reduce Cortisol and Abdominal Fat among Overweight and Obese Women: An Exploratory Randomized Controlled Study. J Obes. 2011;2011:651936. doi: 10.1155/2011/651936 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Kinser PA, Robins JL. Control group design: enhancing rigor in research of mind-body therapies for depression. Evid Based Complement Alternat Med. 2013;2013:140467. doi: 10.1155/2013/140467 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Cohen S, Kamarck T, Mermelstein R. A global measure of perceived stress. Journal of health and social behavior. 1983:385–96. [PubMed] [Google Scholar]
  • 38.Juarascio A, Forman E, Timko CA, Butryn M, Goodwin C. The development and validation of the food craving acceptance and action questionnaire (FAAQ). Eat Behav. 2011;12(3):182–7. doi: 10.1016/j.eatbeh.2011.04.008 [DOI] [PubMed] [Google Scholar]
  • 39.Bostock S, Crosswell AD, Prather AA, Steptoe A. Mindfulness on-the-go: Effects of a mindfulness meditation app on work stress and well-being. Journal of occupational health psychology. 2019;24(1):127. doi: 10.1037/ocp0000118 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Yanovski SZ, Marcus MD, Wadden TA, Walsh BT. The Questionnaire on Eating and Weight Patterns-5: an updated screening instrument for binge eating disorder. The International journal of eating disorders. 2015;48(3):259–61. doi: 10.1002/eat.22372 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Carlson LE, Speca M, Faris P, Patel KD. One year pre–post intervention follow-up of psychological, immune, endocrine and blood pressure outcomes of mindfulness-based stress reduction (MBSR) in breast and prostate cancer outpatients. Brain, Behavior, & Immunity. 2007;21(8):1038–49. doi: 10.1016/j.bbi.2007.04.002 [DOI] [PubMed] [Google Scholar]
  • 42.Hoge EA, Bui E, Marques L, Metcalf CA, Morris LK, Robinaugh DJ, et al. Randomized controlled trial of mindfulness meditation for generalized anxiety disorder: effects on anxiety and stress reactivity. J Clin Psychiatry. 2013;74(8):786–92. doi: 10.4088/JCP.12m08083 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Kristeller J, Hallett CB. An exploratory study of a meditation-based intervention for binge eating disorder. Journal of health psychology. 1999;4(3):357–63. doi: 10.1177/135910539900400305 [DOI] [PubMed] [Google Scholar]
  • 44.Kristeller J, Wolever RQ. Mindfulness-based eating awareness training for treating binge eating disorder: the conceptual foundation. Eating Disorders. 2011;19(1):49–61. doi: 10.1080/10640266.2011.533605 [DOI] [PubMed] [Google Scholar]
  • 45.Kristeller J, Wolever RQ, Sheets V. Mindfulness-based eating awareness training (MB-EAT) for binge eating: A randomized clinical trial. Journal of Mindfulness. 2014;5(3):282–97. [Google Scholar]
  • 46.Mason AE, Epel ES, Aschbacher K, Lustig RH, Acree M, Kristeller J, et al. Reduced reward-driven eating accounts for the impact of a mindfulness-based diet and exercise intervention on weight loss: Data from the SHINE randomized controlled trial. Appetite. 2016;100:86–93. doi: 10.1016/j.appet.2016.02.009 [DOI] [PMC free article] [PubMed] [Google Scholar]

Decision Letter 0

Thomas Tischer

20 Jul 2022

PONE-D-21-38719Impact of digital meditation on work stress and health outcomes among adults with overweight: A randomized, controlled trialPLOS ONE

Dear Dr. Radin,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

The manuscript has been evaluated by two reviewers, including one statistical review. Both reviewers mention some minor points which should be addressed before resubmission of the manuscript. Could you please revise the manuscript to address all their concerns, including provision of the CONSORT checklist?

Please submit your revised manuscript by Sep 02 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Thomas Tischer

Staff Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Thank you for stating in your Funding Statement:

“This work was supported by the UCSF Healthy Campus Network; Headspace, Inc.; and the National Center for Complementary and Integrative Health (NCCIH) K23AT011048-01 (to RMR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.The university’s Institutional review board (IRB) approved all aspects of this study.”

Please provide an amended statement that declares *all* the funding or sources of support (whether external or internal to your organization) received during this study, as detailed online in our guide for authors at http://journals.plos.org/plosone/s/submit-now.  Please also include the statement “There was no additional external funding received for this study.” in your updated Funding Statement.

Please include your amended Funding Statement within your cover letter. We will change the online submission form on your behalf.

3. We note that you have stated that you will provide repository information for your data at acceptance. Should your manuscript be accepted for publication, we will hold it until you provide the relevant accession numbers or DOIs necessary to access your data. If you wish to make changes to your Data Availability statement, please describe these changes in your cover letter and we will update your Data Availability statement to reflect the information you provide.

4. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information.

5. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: No

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: Important note: This review pertains only to ‘statistical aspects’ of the study and so ‘clinical aspects’ [like medical importance, relevance of the study, ‘clinical significance and implication(s)’ of the whole study, etc.] are to be evaluated [should be assessed] separately/independently. Further please note that any ‘statistical review’ is generally done under the assumption that (such) study specific methodological [as well as execution] issues are perfectly taken care of by the investigator(s). This review is not an exception to that and so does not cover clinical aspects {however, seldom comments are made only if those issues are intimately / scientifically related & intermingle with ‘statistical aspects’ of the study}. Agreed that ‘statistical methods’ are used as just tools here, however, they are vital part of methodology [and so should be given due importance].

COMMENTS: It is definitely a good study and is planned as well as executed nicely. However, I have few doubts [these respected actions may be correct but need explanations/clarifications/justifications. Please take them as suggestions]. The first is: ‘Why there were two control groups [active control (‘HE,’ n=41), or waitlist control (‘WL,’ n=42)] in the study?’ [You may know that ‘Permuted Block Randomization’ ensures same group sizes (not]. Role/importance/necessity of ‘waitlist controls’ in any Psychology study is well-known. However, why two control groups?

Next is: Tool used to measure ‘perceived stress’ should have been mentioned in the abstract itself [as it is a Primary Outcome Measure]. In the ‘Abstract-Results’ section you said “Those with greater adherence to MED or MED+HE had greater reductions in stress [, cravings, and adiposity (ps<.05)]” but not mentioned tool or table (where this change is displayed and tested). Much later in line 156, you mentioned that the Perceived Stress Scale (PSS) was used. Is that alright?

The Food Acceptance and Awareness Questionnaire (FAAQ) was used to measure acceptance of urges and cravings to eat. Since the FAAQ is {made up of 10 items, each} rated on a 6-point Likert scale (1=very seldom true to 6=always true) and might have included ‘not true’ (negative) response also, which needs reverse scoring (very often). Also in this context, please note that the following {which is pasted from one standard textbook on ‘Research Methodology’ and I am sure that the authors already know these things, however, it is very essential to keep the limitations in mind while interpreting results [note that I am not asking you to change the study design]}:

Whenever response options ranged from 1=strongly disagree to 4=strongly agree (or ranging from 1 (strongly disagree) to 6 (strongly agree) or from 1=very bad to 3=neither good nor bad to 5=very good), while using a ‘Likert’ scale responses, recoding [like strongly disagree=-2, disagree=-1, neutral=0, agree=1, strongly agree=2] may yield correct and meaningful ‘arithmetic mean’ which is useful not only for comparison but has absolute meaning, in my opinion. Application of any statistical test(s) assume that meaning of entity used (mean, SD, etc) has a particular meaning. Though ‘α’ [alpha] or most other measures of reliability/correlation will remain same, however, use of non-parametric methods should/may be preferred while dealing with data yielded by any questionnaire/score.

Further note that though the measures/tools used are appropriate, most of them yield data that are in [at the most] ‘ordinal’ level of measurement [and not in ratio level of measurement for sure {as the score two times higher does not indicate presence of that parameter/phenomenon as double (for example, a Visual Analogue Scales VAS score or say ‘depression/stress’ score)}]. Then application of suitable non-parametric test(s) is/are indicated/advisable [even if distribution may be ‘Gaussian’ (i.e., normal)]. Agreed that there is/are no non-parametric test(s)/technique(s) available to be used as alternative in all situation(s) [suitable / most desired/applicable], but should be used whenever/wherever they are available.

As you know well that while reporting [findings from] ‘Clinical Trial’ one should follow CONSORT guidelines. Even important items {like How sample size was determined (Item 7a), Random Sequence generation (Item 8a), Allocation concealment (Item 9), Blinding (Item 11a)} of/in CONSORT checklist are not found [since your article type is ‘Clinical Trial’, you are supposed to cover these items in the report]. How you arrived at this sample size [with complete estimation procedure] must be described in details as ultimately you had to say (lines 371-2 that ‘our study was likely limited by a sample size that may have been too small to detect modest interaction effects’}. Fig 1. CONSORT Flow Diagram is alright but covers only about flow of cases/numbers.

There are only two tables in the manuscript – one on baseline demographics and the other on baseline heath characteristics – remaining vital information [mainly comparison statistics] are put/presented in either text or figures. But remember that (in my opinion) figures are complementary and not alternatives of/to tables. One good thing is that there is no statistical comparison of baseline characteristics [read the following]:

To provide a description of baseline characteristics is entirely reasonable (since it is clearly important in assessing to whom the results of the trial can be applied), however, statistical comparison of baseline characteristics is not desirable at all [because even if P-value turns out to be significant (while comparing baseline characteristics despite random allocation), it is, by definition, a false positive] as you then are supposed to be testing ‘randomization’ then, which in any single trial may not balance all baseline characteristics [particularly when sample sizes are small] because ‘randomization’ is a sort of ‘insurance’ and not a guarantee scheme.

Is not it essential to adjust P-value(s) even if ‘series of Analysis of Covariance (ANCOVA)’ are used/applied as it a sort of multiple testing (multiple comparisons) problem/issue?

Except these few points, this manuscript is alright and I have no hesitation to recommend acceptance after minor revision.

Reviewer #2: Title: The coma (,) in the randomized controlled trial shall be excluded.

Materials and Methods:

Under “Interventions”, please specify the frequency (eg. on a daily basis or at least N number of days per week of the 8-weeks intervention. Also, please include how the researchers have verified whether the participants had used the app in the given period.

For HE Group, when was the counseling conducted? Was it at the beginning of the intervention?

Please elaborate on the “digitally-based mindful eating program”. Include name of the app, duration of the mindful eating practice and how the usage per user was assured.

Did you check if the waitlist control group had already access to Headspace or other mindfulness apps like Calm? Have you also considered previous experience of (all) the participants with regard to mindfulness or other meditation practices?

Under “Measures”, please include the reliability and validity of the instruments used.

Discussion and Conclusion: Please separate Conclusion as a distinct section. Highlight the implications of the study at the end of Discussion, and also include delimitations.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: Yes: Dr. Sanjeev Sarmukaddam

Reviewer #2: Yes: Allen Joshua George

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Attachment

Submitted filename: renamed_6f0b7.docx

Attachment

Submitted filename: COMMENTS.docx

PLoS One. 2023 Mar 1;18(3):e0280808. doi: 10.1371/journal.pone.0280808.r002

Author response to Decision Letter 0


3 Sep 2022

Dear Dr. Tischer,

We are pleased to submit a revised version of our research article, entitled Impact of digital meditation on work stress and health outcomes among adults with overweight: A randomized controlled trial for consideration of publication in PLOS ONE. We are grateful for the reviewers’ thoughtful feedback and have included our detailed responses below. We have also highlighted changes throughout our manuscript using tracked changes.

Response to Editor and Reviewer Comments:

Editor’s comments:

• Provision of CONSORT checklist- this is now included

• Include marked up copy of manuscript with tracked changes as well as unmarked version without tracked changes- these are now included

Reviewer #1:

• This review pertains only to ‘statistical aspects’ of the study and so ‘clinical aspects’ [like medical importance, relevance of the study, ‘clinical significance and implication(s)’ of the whole study, etc.] are to be evaluated [should be assessed] separately/independently. Further please note that any ‘statistical review’ is generally done under the assumption that (such) study specific methodological [as well as execution] issues are perfectly taken care of by the investigator(s). This review is not an exception to that and so does not cover clinical aspects (however, seldom comments are made only if those issues are intimately / scientifically related & intermingle with ‘statistical aspects’ of the study). Agreed that ‘statistical methods’ are used as just tools here, however, they are vital part of methodology [and so should be given due importance].

o RESPONSE: Noted. We appreciate this reviewer’s keen insights with regard to statistical aspects of this study. We feel this reviewer’s feedback has greatly enhanced the quality and rigor of the manuscript.

• It is definitely a good study and is planned as well as executed nicely.

o RESPONSE: We thank this reviewer for your positive feedback regarding the manuscript’s methodology.

• Why there were two control groups [active control (‘HE,’ n=41), or waitlist control (‘WL,’ n=42)] in the study?’ [You may know that ‘Permuted Block Randomization’ ensures same group sizes (not]. Role/importance/necessity of ‘waitlist controls’ in any Psychology study is well-known. However, why two control groups?

o RESPONSE: We thank this reviewer for this important question. We felt that the addition of an active control group (‘healthy eating’) which did not include a general mindfulness component, but which was matched for time and attention and other non-specific intervention effects, would allow us to test whether meditation could “out-perform” both a waitlist control (with no treatment or attention components whatsoever) and an active control (that featured some clinical attention and some general health guidelines around eating, generally thought to be a non-specific treatment component for improving eating behavior). The issue of adding an active control group to clinical trials has been receiving more and more attention in recent years, particularly in psychological intervention research, and is generally considered advantageous to a purely waitlist control condition (Kinser & Robins, 2013). We have added this clarification to lines 102-103:

� We aimed to test whether digital meditation could out-perform an active control condition that was matched for time and attention and other non-specific intervention effects (Kinser & Robins, 2013).

• Tool used to measure ‘perceived stress’ should have been mentioned in the abstract itself [as it is a Primary Outcome Measure]. In the ‘Abstract-Results’ section you said “Those with greater adherence to MED or MED+HE had greater reductions in stress [, cravings, and adiposity (ps<.05)]” but not mentioned tool or table (where this change is displayed and tested). Much later in line 156, you mentioned that the Perceived Stress Scale (PSS) was used. Is that alright?

o RESPONSE: We thank this reviewer for noting this oversight. We have added more specificity about primary and secondary outcomes measures to the abstract, on lines 30-31:

� Participants (n=145; M(SD) BMI: 30.8 (5.4) kg/m2) completed baseline and 8-week measures of stress (Perceived Stress Scale), cravings (Food Acceptance and Awareness Questionnaire) and adiposity (sagittal diameter and BMI).

• The Food Acceptance and Awareness Questionnaire (FAAQ) was used to measure acceptance of urges and cravings to eat. Since the FAAQ is (made up of 10 items, each) rated on a 6-point Likert scale (1=very seldom true to 6=always true) and might have included ‘not true’ (negative) response also, which needs reverse scoring (very often). Also in this context, please note that the following (which is pasted from one standard textbook on ‘Research Methodology’ and I am sure that the authors already know these things, however, it is very essential to keep the limitations in mind while interpreting results [note that I am not asking you to change the study design]: Whenever response options ranged from 1=strongly disagree to 4=strongly agree (or ranging from 1 (strongly disagree) to 6 (strongly agree) or from 1=very bad to 3=neither good nor bad to 5=very good), while using a ‘Likert’ scale responses, recoding [like strongly disagree=-2, disagree=-1, neutral=0, agree=1, strongly agree=2] may yield correct and meaningful ‘arithmetic mean’ which is useful not only for comparison but has absolute meaning, in my opinion. Application of any statistical test(s) assume that meaning of entity used (mean, SD, etc) has a particular meaning. Though ‘α’ [alpha] or most other measures of reliability/correlation will remain same, however, use of non- parametric methods should/may be preferred while dealing with data yielded by any questionnaire/score.

o RESPONSE: We thank this reviewer for noting the limitation of the way in which the FAAQ is scored using a 6-point Likert scale, without the option for negative or not true responses. We have kept the scoring to be consistent with conventional scoring approaches for this measure (Juarascio, Forman, Timko, Butryn, & Goodwin, 2011), to ensure ease of comparison of FAAQ scores across manuscripts. However, we acknowledge this scoring limitation in our discussion section, on lines 467-470:

� Further, our measures of dysregulated eating may not fully reflect non-homeostatic eating behavior (vs. a semi-structured interview measure of eating pathology), and the scoring metrics for the FAAQ (a 6-point Likert scale ranging from 1 to 6) without the option for including negative (e.g., -1, -2) response may not yield particularly meaningful arithmetic means.

• Further note that though the measures/tools used are appropriate, most of them yield data that are in [at the most] ‘ordinal’ level of measurement [and not in ratio level of measurement for sure (as the score two times higher does not indicate presence of that parameter/phenomenon as double (for example, a Visual Analogue Scales VAS score or say ‘depression/stress’ score)]. Then application of suitable non-parametric test(s) is/are indicated/advisable [even if distribution may be ‘Gaussian’ (i.e., normal)]. Agreed that there is/are no non-parametric test(s)/technique(s) available to be used as alternative in all situation(s) [suitable / most desired/applicable], but should be used whenever/wherever they are available.

o RESPONSE: We thank this reviewer for noting the limitation of survey measures that yield data in the ordinal level of measurement (e.g., PSS, FAAQ). Per this reviewer’s suggestion, we have run non-parametric tests (Kruskal-Wallis test, instead of ANOVA) for outcome measures using ordinal level measurement (PSS and FAAQ) where possible, and yielded nearly identical findings as with our parametric tests. Due to space limitations we have not included these findings in the manuscript, but we acknowledge the following on lines 322-323, and lines 342-343:

� Findings were identical when using non-parametric tests (Kruskal-Wallis), given the ordinal nature of the PSS scoring.

� Findings were identical when using non-parametric tests (Kruskal-Wallis), given the ordinal nature of the FAAQ scoring.

• As you know well that while reporting [findings from] ‘Clinical Trial’ one should follow CONSORT guidelines. Even important items (like How sample size was determined (Item 7a), Random Sequence generation (Item 8a), Allocation concealment (Item 9), Blinding (Item 11a)) of/in CONSORT checklist are not found [since your article type is ‘Clinical Trial’, you are supposed to cover these items in the report]. How you arrived at this sample size [with complete estimation procedure] must be described in details as ultimately you had to say (lines 371-2 that ‘our study was likely limited by a sample size that may have been too small to detect modest interaction effects’). Fig 1. CONSORT Flow Diagram is alright but covers only about flow of cases/numbers.

o RESPONSE: We thank this reviewer for noting this oversight. Most of these details required by CONSORT guidelines are contained within our Supplemental CONSORT Study protocol, which has now been submitted to the editor. We have also added most of these details throughout the manuscript. For instance, on lines 133-136 and on lines 142-148, respectively, we have added the following:

� We aimed to enroll up to 150 participants. Our prior study (Bostock, Crosswell, Prather, & Steptoe, 2019) detected effects in a sample of <250 participants. We therefore expected that our sample size of 150 would be well-powered to detect improvements in our self-report measures in response to our treatment intervention.

� Study personnel then randomly assigned participants to one of four possible conditions, using factorial assignment, on Qualtrics…. Study personnel were not able to access the file containing the sequence of assignments or to see the next condition in the sequence until the moment they randomized the participant.

• There are only two tables in the manuscript – one on baseline demographics and the other on baseline heath characteristics – remaining vital information [mainly comparison statistics] are put/presented in either text or figures. But remember that (in my opinion) figures are complementary and not alternatives of/to tables. One good thing is that there is no statistical comparison of baseline characteristics [read the following]:

To provide a description of baseline characteristics is entirely reasonable (since it is clearly important in assessing to whom the results of the trial can be applied), however, statistical comparison of baseline characteristics is not desirable at all [because even if P-value turns out to be significant (while comparing baseline characteristics despite random allocation), it is, by definition, a false positive] as you then are supposed to be testing ‘randomization’ then, which in any single trial may not balance all baseline characteristics [particularly when sample sizes are small] because ‘randomization’ is a sort of ‘insurance’ and not a guarantee scheme.

o RESPONSE: We thank this reviewer for this comment and completely agree that baseline characteristics should not include any sort of statistical comparison. We also agree with this reviewer that figures are considered complementary, and have thus included all relevant and necessary statistics pertaining to these figures within the text of the manuscript.

• Is not it essential to adjust P-value(s) even if ‘series of Analysis of Covariance (ANCOVA)’ are used/applied as it a sort of multiple testing (multiple comparisons) problem/issue?

o RESPONSE: We thank this reviewer for this keen observation regarding multiple comparisons using ANCOVA. Notably, all of our results remained similar when adjusting for multiple comparisons (using a Bonferroni adjusted alpha level of .03 (.05/2) for each ANCOVA model).

• Except these few points, this manuscript is alright and I have no hesitation to recommend acceptance after minor revision.

o RESPONSE: We thank this reviewer for your positive feedback regarding the overall quality of the manuscript, and appreciate the keen attention to statistical concerns throughout.

Reviewer #2:

• Title: The coma (,) in the randomized controlled trial shall be excluded.

o RESPONSE: We thank this reviewer for noting this oversight and have removed the comma from the title (Line 4).

• Materials and Methods:

• Under “Interventions”, please specify the frequency (e.g.. on a daily basis or at least N number of days per week of the 8-weeks intervention.

o RESPONSE: We have added frequency of contact/involvement for each intervention category. Lines 155-186 now say:

� Meditation group (‘MED’)…Participants were expected to meditate 5 days per week over the course of 8 weeks

� Healthy eating group (‘HE’)… Participants had a total of approximately 1.5-2 hours of contact with a counselor, and were expected to engage with the online resources 1 day per week over the course of 8 weeks.

� Meditation + Healthy eating group (‘MED+HE’)… Participants were expected to meditate 5 days per week over the course of 8 weeks and they had a total of approximately 1.5-2 hours of contact with a counselor, and were expected to engage with the online resources 1 day per week over the course of 8 weeks.

� Waitlist control condition (‘WL’)… Participants had no contact with a study counselor over the course of the 8 week intervention period.

• Also, please include how the researchers have verified whether the participants had used the app in the given period.

o RESPONSE: The research team had access to user data through Headspace, and were able to calculate total number of minutes spent meditating. This information has been added to lines 238-239:

� The research team had access to individual user data via Headspace, in order to make these calculations.

• For HE Group, when was the counseling conducted? Was it at the beginning of the intervention?

o RESPONSE: The counseling session was conducted at the very beginning of the intervention, within week one. This information has been added to line 158.

• Please elaborate on the “digitally-based mindful eating program.” Include name of the app, duration of the mindful eating practice and how the usage per user was assured.

o RESPONSE: The digitally-based mindful eating program was created specifically for this study by the research team, and was primarily a secured website that included information on mindful eating, and audio tools for mindful eating practice (~3-5 minute practices). These details have now been added to lines 164-166.

• Did you check if the waitlist control group had already access to Headspace or other mindfulness apps like Calm? Have you also considered previous experience of (all) the participants with regard to mindfulness or other meditation practices?

o RESPONSE: We did not provide Headspace access codes to WL participants until after they completed a 2-month follow-up questionnaire. However, we had no way of objectively verifying whether participants already had subscriptions to other mindfulness apps. We excluded individuals who indicated they were experienced meditators (defined as 3 times per week for 10 minutes or more), and at baseline, participants reported meditating less than once a week; in fact, the majority (79%) indicated that they had never meditated, and only 4% indicated that they meditated 1-2 times per week prior to treatment randomization (Table 2). Given that so few individuals indicated prior experience with meditation, we did not examine this baseline characteristic as a treatment covariate. We have noted the limitation of being unable to objectively verify access to meditation programs for those in our control conditions to lines 465-467:

� We were unable to truly ascertain whether participants in either control condition were accessing mindfulness programs or apps during the 8 week intervention period.

• Under “Measures”, please include the reliability and validity of the instruments used.

o RESPONSE: We appreciate this feedback, and we have now included relevant psychometric properties of each of the instruments used (PSS, FAAQ, and QEWP-5) throughout the measures section (Lines 193-231).

• Discussion and Conclusion:

• Please separate Conclusion as a distinct section.

o RESPONSE: We have now created a Conclusion section that is distinct from the Discussion section (Line 473), and which highlights the clinical implications of the study.

Attachment

Submitted filename: Response to Reviewers.pdf

Decision Letter 1

Clare Mc Fadden

4 Oct 2022

PONE-D-21-38719R1Impact of digital meditation on work stress and health outcomes among adults with overweight: A randomized controlled trialPLOS ONE

Dear Dr. Radin,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Thank you for revising the manuscript and providing detailed responses to the previous reviews. The two original reviewers provided positive comments on the revisions, and their comments are available below. The manuscript mentions a "digitally-based mindful eating program" which was created for this study and provided to participants via a secured website> However it is not clear what this program entailed, how it was designed and if it is intended to be provided as a commercial product. Please respond to the editor's queries regarding this issue. Editor's queries:Please provide further information on the “digitally-based mindful eating program.” 

- Please include in the manuscript a brief outline of the material in the digitally-based mindful eating program and how it was designed.

- Are there any previous publications describing the program or research that underpins it? If so please cite them in the manuscript.

- Is there any public-facing information about the program accessible to readers? If so, please add links to relevant webpages as citation(s). Guidelines for formatting references to online sources are here: https://journals.plos.org/plosone/s/submission-guidelines#loc-references

- Is the program associated with a commercial provider and/or patent or is it intended to be provided commercially in the future? If so, are any of the authors associated with the commercial provider or patent? Please review PLOS's Competing Interest policy and ensure all potential competing interests are declared (https://journals.plos.org/plosone/s/competing-interests

Please submit your revised manuscript by Nov 17 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Clare Mc Fadden, PhD

Staff Editor

PLOS ONE

Journal Requirements:

Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: All comments have been addressed

Reviewer #2: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: (No Response)

Reviewer #2: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: (No Response)

Reviewer #2: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: (No Response)

Reviewer #2: No

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: (No Response)

Reviewer #2: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: COMMENTS: Since all of the comments made on earlier draft are considered positively & attended, I recommend the acceptance. The manuscript now has achieved acceptable level, in my opinion.

Very nice that [“we have run non-parametric tests (Kruskal-Wallis test, instead of ANOVA) for outcome measures using ordinal level measurement (PSS and FAAQ) where possible”. However, remember that even if they yielded nearly identical findings as with parametric tests, it is always good to apply correct/indicated ones.

Reviewer #2: After revision the manuscript has better clarity and structure. The authors have addressed all the previous recommendations.

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: Yes: Dr. Sanjeev Sarmukaddam

Reviewer #2: Yes: Allen Joshua George

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2023 Mar 1;18(3):e0280808. doi: 10.1371/journal.pone.0280808.r004

Author response to Decision Letter 1


17 Nov 2022

We are pleased to submit a revised version of our research article, entitled Impact of digital meditation on work stress and health outcomes among adults with overweight: A randomized controlled trial for consideration of publication in PLOS ONE. We are pleased to learn that the previous peer reviewers were satisfied with our edits and responsiveness to earlier feedback. We are grateful for your thoughtful additional feedback and have included our detailed responses below. We have also highlighted changes throughout our manuscript using tracked changes.

Response to Editor Comments:

Editor’s queries:

• The manuscript mentions a "digitally-based mindful eating program" which was created for this study and provided to participants via a secured website. However, it is not clear what this program entailed, how it was designed and if it is intended to be provided as a commercial product. Please respond to the editor's queries regarding this issue. Please provide further information on the “digitally-based mindful eating program.” Please include in the manuscript a brief outline of the material in the digitally-based mindful eating program and how it was designed.

o RESPONSE: We developed a brief mindful eating program for this study, geared towards helping participants develop goals to improve eating behavior (e.g., to reduce compulsive eating and increase mindful eating). This program was in the early, pilot stages (NCT03945214, funded through the first author’s K23: 1K23AT011048) to assess feasibility and acceptability. Given its early stages of development, the program is not intended to be provided as a commercial product. It is in need of further refinement and tailoring for specific populations who struggle with binge eating before it can be offered as a commercial product. The program included a combination of both an in-person motivational-interviewing-based counseling session, text message support, and access to a website that provided audio exercises and tools to practice eating mindfully, including tools to ride out urges to overeat. The audio exercises were scripted and recorded by the study’s first author and adapted from a number of mindful eating resources including the MB-EAT curriculum.

We developed the brief mindful eating program for this study, geared towards helping participants develop goals to reduce compulsive eating and increase mindful eating. This program was in the pilot stages to assess feasibility and acceptability. The program is adapted from several sources, including motivational interviewing for binge eating,1 weight management,2,3 and sugar-sweetened beverage intake (from our recently completed trial),4 and mindfulness-based eating awareness training.5 The program is comprised of an initial one-on-one counseling session, three booster calls during the 8-week intervention period, engagement with an online mindful eating program with instruction on mindful eating practices, and text message reminders of support three times a week. During the session, trained health counselors follow a semi-structured protocol of: (1) engaging participants in a conversation about the concerns they have about their eating (2) identifying vulnerabilities for challenging eating patterns, (3) asking participants to consider why/how making changes to eating would be important for them, (4) identifying perceived barriers to changing eating habits, (5) providing psychoeducation on sugar intake, stress eating, and their links with health, (6) collaborating with participants on specific, achievable eating-related goals, (7) identifying motivational factors, (8) engaging participants to rate level of confidence and self-efficacy in making changes, and (9) guiding participants through a brief mindful eating exercise using a bite-sized snack of their choice. Participants were then given access to a password-secured website which contained up to six different brief audio exercises using mindful eating and urge-surfing strategies. They were instructed to access these audios during high vulnerability times for compulsive eating. For example, for those who identify cravings as a potent trigger for problematic consumption, participants could access a brief urge-surfing exercise to learn how to ‘ride out’ a craving.

The following details about the digital component of the program have now been added to the manuscript (lines 157-163):

� This password-secured website contained up to six different brief audio exercises using mindful eating and urge-surfing strategies. The audio exercises were scripted and recorded by the study’s first author and adapted from a number of mindful eating resources including the MB-EAT curriculum. We instructed participants to access these audios during high vulnerability times for compulsive eating. For example, for those who identify cravings as a potent trigger for problematic consumption, participants could access a brief urge-surfing exercise to learn how to ‘ride out’ a craving.

• Are there any previous publications describing the program or research that underpins it? If so please cite them in the manuscript.

o RESPONSE: The program is adapted from several sources, including motivational interviewing for binge eating,1 weight management,2,3 and sugar-sweetened beverage intake (from our recently completed trial),4 and mindfulness-based eating awareness training.5 However, the current manuscript is the first to describe the program in its current form. The following details have now been added to the manuscript (lines 165-167):

� The program is adapted from several sources, including motivational interviewing for binge eating,1 weight management,2,3 and sugar-sweetened beverage intake (from our recently completed trial),4 and mindfulness-based eating awareness training.5

• Is there any public-facing information about the program accessible to readers? If so, please add links to relevant webpages as citation(s). Guidelines for formatting references to online sources are here: hfps://journals.plos.org/plosone/s/submission-guidelines#loc-references

o RESPONSE: This program was in the early, pilot stages (NCT03945214, funded through the first author’s K23: 1K23AT011048) to assess feasibility and acceptability. Given its early stages of development, the program is not yet accessible to readers in public-facing formats such as public webpages.

• Is the program associated with a commercial provider and/or patent or is it intended to be provided commercially in the future? If so, are any of the authors associated with the commercial provider or patent? Please review PLOS's Competing Interest policy and ensure all potential competing interests are declared (hfps://journals.plos.org/plosone/s/compeUng-interests)

o RESPONSE: As described previously, this program was in the early, pilot stages (NCT03945214, funded through the first author’s K23: 1K23AT011048) to assess feasibility and acceptability. Given its early stages of development, the program is not intended to be provided as a commercial product. It is in need of further refinement and tailoring for specific populations who struggle with binge eating before it can be offered as a commercial product.

Attachment

Submitted filename: Response to Reviewers_2022-11-17.docx

Decision Letter 2

Yann Benetreau

10 Jan 2023

Impact of digital meditation on work stress and health outcomes among adults with overweight: A randomized controlled trial

PONE-D-21-38719R2

Dear Dr. Radin,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Yann Benetreau

Staff Editor

PLOS ONE

Additional Editor Comments (optional):

With apologies for the lengthy review time. Please ensure that the formatting of references adheres to our submission guidelines at https://journals.plos.org/plosone/s/submission-guidelines#loc-references

Reviewers' comments:

Acceptance letter

Yann Benetreau

2 Feb 2023

PONE-D-21-38719R2

Impact of digital meditation on work stress and health outcomes among adults with overweight: A randomized controlled trial

Dear Dr. Radin:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Yann Benetreau

Staff Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Checklist. CONSORT 2010 checklist of information to include when reporting a randomised trial*.

    (DOC)

    S1 File

    (DOCX)

    S2 File

    (PDF)

    Attachment

    Submitted filename: renamed_6f0b7.docx

    Attachment

    Submitted filename: COMMENTS.docx

    Attachment

    Submitted filename: Response to Reviewers.pdf

    Attachment

    Submitted filename: Response to Reviewers_2022-11-17.docx

    Data Availability Statement

    The data described in the manuscript, code book, and analytic code/syntax are made publicly and freely available through Open Science Framework Repository. The DOI Identifier is: DOI 10.17605/OSF.IO/QPG6F.


    Articles from PLOS ONE are provided here courtesy of PLOS

    RESOURCES